Freedom Day Solutions, LLC Gilead Sciences, Inc. Transaction History

Freedom Day Solutions, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 28, 2019	SELL	$60.54 - $79.0 $1.47 Million - $1.92 Million	-24,272 Closed	0 $0
Q3 2018 Oct 15, 2018	SELL	$71.28 - $78.92 $137,641 - $152,394	-1,931 Reduced 7.37%	24,272 $1.87 Million
Q2 2018 Jul 12, 2018	BUY	$64.88 - $75.68 $7,655 - $8,930	118 Added 0.45%	26,203 $1.86 Million
Q1 2018 Apr 13, 2018	SELL	$72.84 - $88.8 $61,768 - $75,302	-848 Reduced 3.15%	26,085 $1.97 Million
Q4 2017 Feb 07, 2018	BUY	$71.15 - $83.52 $1.92 Million - $2.25 Million	26,933	26,933 $1.93 Million

1,993

993M

10.1M

8.85M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $120B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Freedom Day Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Freedom Day Solutions, LLC with notifications on news.